Specifically, APOE ε2 has shown neuroprotective effects (48) and the early post-ICH deficits linked to it are transient, while APOE ε4 is a significant risk factor for VaD and AD (49) and the associated post-ICH CI show a delayed build over time. Here, APOE is linked to Alzheimer disease.